Novartis Announces Enormous Clinical Trial Program For Heart Failure Drug

–The company plans to perform 40 clinical trials in 5 years with Entresto. Novartis announced today an enormous clinical trial program with its promising but slow starting heart failure drug Entresto (valsartan/sacubitril). The company said it would perform 40 clinical trials with the drug in the next five years. The Fortifying Heart Failure clinical evidence and...Click here to continue reading...
Source: CardioBrief - Category: Cardiology Authors: Tags: Heart Failure People, Places & Events clinical trials Entresto LCZ Source Type: blogs